Unbundling the Value Chain: Business Models from Digital Infrastructure to Physical ScaleGlobal Report·Jul 14 at 06:47 AMCHRS0.00%REI+2.34%
Capital Reallocation and Physical Constraints: The Barbell Market of 2026Global Report·Jul 8 at 10:32 PMKALA-17.14%GENK-0.54%
Pre-market hot trades in US stocks: Kala Bio up 9.83% in pre-market, active funds but no positive newsPrice Alert·Jul 1 at 05:37 AMKALA-17.14%
U.S. stock market midday update: KALA BIO rises 20.21%, gene-editing ophthalmic therapy in demandPrice Alert·Jun 18 at 11:27 AMKALA-17.14%
Rebundling the Tech Stack: How Hardware and AI Reshape the Value ChainGlobal Report·Jun 18 at 07:46 AMLUMN-2.54%FIVN-5.25%
KALA BIO, Inc. 1Q 2026: Net loss $(1.6M), Diluted EPS $(0.14) — 10-Q SummaryTradingView·May 15 at 02:41 PMKALA-17.14%LABU+4.00%
U.S. stock night market volatility: Kala Bio fell 10.58% in after-hours trading, with no significant news but showing volatility. What is causing such market sentiment?Price Alert·May 13 at 12:11 AMKALA-17.14%
KALA BIO Stock Scheduled to Reverse Split on Monday, May 11th (NASDAQ:KALA)Market Beat·May 7 at 06:01 PMKALA-17.14%ARKG-8.00%
KALA BIO shares are trading lower after the company announced a 1-for-50 reverse stock split.benzinga_article·May 7 at 08:24 AMKALA-17.14%LABU+4.00%
U.S. stock movement quick report: Moolec Science surged 37.58%, Rambus plummeted 15.08%, attracting market attentionPrice Alert·Apr 28 at 02:00 AMMLEC-2.97%RMBS-0.62%
12 Health Care Stocks Moving In Monday's After-Market Sessionbenzinga_article·Apr 27 at 04:05 PMTRVI-1.04%ADVB+36.98%
KALA BIO (NASDAQ:KALA) Posts Quarterly Earnings ResultsMarket Beat·Apr 15 at 03:30 PMKALA-17.14%IBB+1.06%